Erroneous Payment Corrections for Various Grifols Products

December 1, 2020

Effective for dates of service on or after April 1, 2020, and July 1, 2020, Grifols restated prices that may affect reimbursement for Profilnine (500IU and 1,000IU), Alphanate (250IU, 500IU and 1,000IU), and Alphanine (500IU and 1,000IU) products. These reimbursements will be automatically adjusted to reflect the accurate values restated.

No action is required of providers. An Erroneous Payment Correction (EPC) will be implemented to reprocess the affected claims.